Physician Leader ThedaCare Cancer Center
Oncology
Matthias Weiss, MD is an expert in the field of Oncology. He has 1 awards "Meaningful Use Stage 1 Certification". Matthias Weiss has written publications. He has 3 publications published with PubMed. The lastest paper is: 'Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protoco...' Matthias Weiss accepts Medicare payments and is listed with Medicare.gov.
Publications
Schools
RuprechtKarlsUniversitaet Heidelberg Medizinische Gesamtfakultat
Military Hospital
Gundersen Med Fdn
Mayo Clinic Rochester
Albert Ludwigs University Of Freiburg
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- American Enterprise Group
- American Republic
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- National Elevator
- PHP-Physicians Health Plan
- Pipefitters
- Thrivent Financial
- Choice Plus POS
- Navigate POS
- Options PPO
Awards
- Meaningful Use Stage 1 Certification
Education
-
Mayo School of Graduate Medical Education
-
Ruprecht Karl University Faculty of Medicine
Drug Facts
NPI NUMBER |
|
1245336759 |
NPPES Provider LastName |
|
WEISS |
NPPES Provider FirstName |
|
MATTHIAS |
NPPES Provider ZIPCode |
|
549113454 |
NPPES Provider State |
|
WI |
Specialty Description |
|
Hematology/Oncology |
Total Claim Count |
|
815.0 |
Distinct Opioid Count |
|
3.0 |
Opioid Claim Count |
|
67.0 |
Percent Opioid Claims |
|
8.22 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1245336759 |
Last Name Of The Provider |
WEISS |
First Name Of The Provider |
MATTHIAS |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog